全文获取类型
收费全文 | 124745篇 |
免费 | 12484篇 |
国内免费 | 7776篇 |
专业分类
耳鼻咽喉 | 1262篇 |
儿科学 | 1709篇 |
妇产科学 | 1233篇 |
基础医学 | 12578篇 |
口腔科学 | 2175篇 |
临床医学 | 16117篇 |
内科学 | 16992篇 |
皮肤病学 | 1834篇 |
神经病学 | 5322篇 |
特种医学 | 5075篇 |
外国民族医学 | 42篇 |
外科学 | 12076篇 |
综合类 | 23962篇 |
现状与发展 | 23篇 |
一般理论 | 10篇 |
预防医学 | 10603篇 |
眼科学 | 3017篇 |
药学 | 14027篇 |
142篇 | |
中国医学 | 8338篇 |
肿瘤学 | 8468篇 |
出版年
2024年 | 503篇 |
2023年 | 1928篇 |
2022年 | 4846篇 |
2021年 | 6384篇 |
2020年 | 5009篇 |
2019年 | 3936篇 |
2018年 | 4100篇 |
2017年 | 4074篇 |
2016年 | 3934篇 |
2015年 | 6099篇 |
2014年 | 7654篇 |
2013年 | 7811篇 |
2012年 | 11464篇 |
2011年 | 11752篇 |
2010年 | 8600篇 |
2009年 | 7060篇 |
2008年 | 7879篇 |
2007年 | 7439篇 |
2006年 | 7034篇 |
2005年 | 6048篇 |
2004年 | 4127篇 |
2003年 | 3602篇 |
2002年 | 2978篇 |
2001年 | 2058篇 |
2000年 | 1703篇 |
1999年 | 1486篇 |
1998年 | 805篇 |
1997年 | 845篇 |
1996年 | 627篇 |
1995年 | 550篇 |
1994年 | 488篇 |
1993年 | 286篇 |
1992年 | 320篇 |
1991年 | 288篇 |
1990年 | 246篇 |
1989年 | 178篇 |
1988年 | 161篇 |
1987年 | 140篇 |
1986年 | 114篇 |
1985年 | 86篇 |
1984年 | 71篇 |
1983年 | 44篇 |
1982年 | 25篇 |
1981年 | 24篇 |
1980年 | 22篇 |
1979年 | 25篇 |
1978年 | 21篇 |
1975年 | 12篇 |
1974年 | 16篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
鼻内窥镜下鼻中隔矫正术 总被引:5,自引:1,他引:4
目的 :研究鼻内窥镜下鼻中隔矫正术的优点。方法 :鼻内窥镜下鼻中隔矫正术 5 0例 ,同期施行传统的鼻中隔矫正术 5 0例作为对照 ,分析两者手术时间、术中出血量及疼痛情况。结果 :鼻内窥镜组治愈率为96% ,手术时间 ( 35 .5 0± 5 .2 0 ) min,术中出血量 ( 2 3.2 2± 4.2 5 ) ml,疼痛发生率为 1 6% ;传统手术组治愈率为 90 % ,手术时间 ( 4 5 .64± 6.34) min,术中出血量 ( 31 .34± 5 .64) ml,疼痛发生率为 38%。经统计学分析两组治愈率差异无显著性 ( P>0 .0 5 ) ,鼻内窥镜组手术时间明显缩短 ( P<0 .0 1 ) ,术中出血量明显减少 ( P<0 .0 5 ) ,术中疼痛发生率明显降低 ( P<0 .0 5 )。结论 :鼻内窥镜下鼻中隔矫正术照明好 ,术野清晰 ,直视下手术 ,易剥离粘连处和及时发现粘膜损伤 ,手术时间短 ,术中出血量少 ,疼痛轻 ,术后并发症少 ,特别是鼻中隔矫正同期完成功能性鼻内窥镜手术及歪鼻矫正手术时更显示其优越性 相似文献
72.
保留肾单位手术治疗早期小肾癌21例临床分析 总被引:1,自引:0,他引:1
Yao-Jun Xiao Shao-Bin Zheng Wan-Long Tan Tong Chen Huan Qi Zhi-Qiang Shao Yao-Dong Jiang Peng Wu Hui-Jian Zhang 《第一军医大学学报》2005,25(3):357-359
OBJECTIVE: To evaluate the clinical effects of nephron-sparing surgery in patients with early-stage small renal cell carcinoma. METHODS: Nephron-sparing surgery was performed in 21 patients with renal cell carcinoma including 1 with solitary kidney, 3 with unilateral tumor and contralateral renal compromise, and 17 with unilateral tumor and normal contralateral kidney. The diameter of the tumors ranged from 1.5 to 6.0 cm, with a mean of 2.8 cm. The tumor diameter in 17 patients with normal contralateral kidney was less than 4 cm (mean 2.5 cm) and the average diameter in 4 patients with contralateral renal compromise was 4.2 cm. Sixteen cases were in stage T(1), 4 in stage T(2), and 1 in stage T(3). Of the 21 patients, 4 underwent tumor enucleation, 10 polar nephrectomy and 7 wedge resection. RESULTS: All patients were followed up for an average of 40.8 months (7 to 66 months). One patient suffered a right lung and mediastinum metastasis 3 years after the surgery later and 1 with chronic glomerulonephritis required dialysis 27 months after the operation. No surgical complication or local recurrence were found in other patients. CONCLUSION: As a safe and effective therapy for early-stage small renal cell carcinoma, nephron-sparing surgery can be considered as the gold-standard therapy for patients with lesions less than 4 cm in T(1) and T(2) stages of localized unilateral tumor with normal contralateral kidney. 相似文献
73.
Objective To test the hypothesis that p53 gene therapy combined with endostatin can enhance tumor response to radiation therapy of RM-1 mouse xenograft prostate cancer and to investigate its mechanism. Methods A mouse prostate cancer model was established. Then mice with xenograft tumor were randomly divided into group A (control), B (radiation), C (radiation and rAdp53), D (radiation and rh-endostatin) and E (radiation and rAdp53 and rh-endostatin). On day 1, rAdp53 was injected intra-tumorously with 1 × 1010 vp per animal to group C and E. From day 1 to 14, rh-endostatin was given 15 mg/kg intraperitoneally daily to group D and E. On day 4 single fraction of 15 Gy was given to tumors in groups B, C, D and E. Normal saline was injected intra-tumorously or intraperitoneaUy accordingly as control. No treatment was done to group A. Tumor volume was measured daily. Samples were collected on Days 5, 10 and 15. Ki67, CD31, p53 and VEGF were detected by means of immunohistochemistry. Results (1) Radiation alone, radiation combined with intra-tumorous injection of Adp53 and/or intraperitoneal injection of rh-endostatin resulted in tumor growth arrest of RM-1 cells in vivo (P = 0.000). Radiation combined with both rAdp53 and rh-endostatin was the most effective treatment (P < 0.05). (2) All the four treatment groups had a decreased expression of mutant type P53 (P = 0.000). The expression of Ki67 in groups B and C were equal (P 0.05) and increasing (P = 0.000), respectively. Group D had a up-down-up curve (P < 0.05), but group E had a up-down one. On day 5 the expresion of VEGF in group E was the lowest (P < 0.05). An increased expression of MVD compared with the control was shown, and MVD in groups C, D and E were always higher than that in the control (P < 0.05). Conclusions The limitation of radiotherapy could be overcome by combination with beth p53 gene therapy and endostatin on the growth of mouse prostate cancer cell. Radiation, rAdp53 and endostatin have their own role but they can be interacted with each other. 相似文献
74.
75.
76.
Penny H Feldman Christopher M Murtaugh Liliana E Pezzin Margaret V McDonald Timothy R Peng 《Health services research》2005,40(3):865-886
OBJECTIVE: To assess the impact and cost-effectiveness of two information-based provider reminder interventions designed to improve self-care management and outcomes of heart failure (HF) patients. DATA SOURCES/STUDY SETTING: Interview and agency administrative data on 628 home care patients with a primary diagnosis of HF. STUDY DESIGN: Patients were treated by nurses randomly assigned to usual care or one of two intervention groups. The basic intervention was an e-mail to the patient's nurse highlighting six HF-specific clinical recommendations. The augmented intervention supplemented the initial nurse reminder with additional clinician and patient resources. DATA COLLECTION: Patient interviews were conducted 45 days post admission to measure self-management behaviors, HF-specific outcomes (Kansas City Cardiomyopathy Questionnaire-KCCQ), health-related quality of life (EuroQoL), and service use. PRINCIPAL FINDINGS: Both interventions improved the mean KCCQ summary score (15.3 and 12.9 percent, respectively) relative to usual care (p< or =.05). The basic intervention also yielded a higher EuroQoL score relative to usual care (p< or =.05). In addition, the interventions had a positive impact on medication knowledge, diet, and weight monitoring. The basic intervention was more cost-effective than the augmented intervention in improving clinical outcomes. CONCLUSIONS: This study demonstrates the positive impact of targeting evidence-based computer reminders to home health nurses to improve patient self-care behaviors, knowledge, and clinical outcomes. It also advances the field's limited understanding of the cost-effectiveness of selected strategies for translating research into practice. 相似文献
77.
目的通过是否进行腭咽肌肉重建的两组腭裂修复术后患者鼻咽内窥镜的比较观察,了解腭咽部肌肉重建术后腭咽闭合状况的改变。方法将41例腭裂术后患者,按照在腭裂修复时是否进行腭咽肌肉重建分为重建组(22例)和非重建组(19例),以鼻咽纤维内窥镜记录静态和发音时腭咽闭合运动状况,对两组患者腭咽闭合运动类型和状况进行比较。结果重建组静态腭咽腔形态较非重建组明显缩小,各壁光滑丰满,未见软腭鼻腔面V型缺损畸形;动态时以环状闭合为主。非重建组静态腭咽腔形态较大,可见软腭鼻腔面V型缺损畸形;动态时以冠状闭合为主。经比较重建组腭咽闭合良好率(90.91%)明显优于非重建组(37.31%)。结论鼻咽内窥镜观察证实腭咽肌肉重建腭裂修复术后腭咽闭合功能恢复明显优于非重建组。腭裂修复术时重建腭咽肌肉有助于缩小腭咽腔和更易于达到良好的腭咽闭合状态。 相似文献
78.
目的 探讨介入治疗下肢深静脉血栓(deep venous thrombosis,DVT)的效果. 方法 38例DVT均行深静脉置管接触性溶栓,12例联合血管球囊扩张及血管内支架置入术.按我院疗效观察标准:治愈,造影检查示血栓完全溶解,静脉壁光滑;显效,静脉回流通畅,静脉内有附壁血栓,管腔内径≥2/3;有效,静脉内仍有血栓残留,管腔内径<2/3;无效,造影检查示静脉回流不通畅. 结果 治愈22例,显效14例,有效2例.治疗中无严重并发症发生.34例随访3~24个月,其中3~6个月7例,7~12个月12例,13~24个月15例,血栓复发2例,经再次深静脉置管接触性溶栓治疗后部分再通. 结论 介入治疗DVT操作简便,安全有效. 相似文献
79.
目的应用显微手术夹闭、血管内栓塞和栓塞后手术夹闭3种治疗方法,探讨治疗颅内破裂动脉瘤的安全有效方案。方法显微手术瘤颈夹闭30个动脉瘤,栓塞34个动脉瘤,栓塞后夹闭15个动脉瘤。结果夹闭组30个完全夹闭,无复发,死亡率6%(2/30)。栓塞组完全闭塞率70.6%(24/34),复发率17.6%(6/34),死亡率11.8%(4/34)。栓塞后手术组15个完全夹闭,无复发,死亡率6.7%(1/15)。治疗结束用GOS评价,1个月后3组良好率分别为80.0%、79.4%和80.0%;半年后良好率分别为90.0%、88.2%和86.7%。结论显微手术瘤颈夹闭术仍然是治疗破裂动脉瘤的有效方法,具有1次治疗彻底和复发率低的优势,并可作为栓塞失败的补救手段。 相似文献
80.
CT导向下经皮射频消融术治疗肾上腺恶性肿瘤 总被引:4,自引:0,他引:4
目的对29例肾上腺肿瘤患者行射频消融(RFA)治疗,研究其近期局部治疗效果、不良反应和副作用。方法肾上腺肿瘤患者共29例,病灶总数31个,其中直径≤2.0cm的病灶共5个,2.1-4.0cm者18个,4.1-6.0cm者5个,≥6.1cm者3个,经RFA治疗1个月后行螺旋CT双期增强扫描评价肿瘤治疗效果。结果上述病灶经消融治疗后达到完全坏死者分别为5个、18个、3个、2个。患者无严重并发症出现。结论RFA治疗安全可靠,副作用小,是治疗肾上腺恶性肿瘤的有效方法之一。 相似文献